ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited health care resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author. Credentialed media can access published articles on the ASCO Publications site using their login information.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing March 23, 2023, 4:00 PM ET:

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer (Original Report)
Kim Chi et al.
Request article

Combining PARP Inhibitors with Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary? (Editorial)
Emmanuel Antonarakis, et al.
Request article

Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients with ROS1-rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study (Original Report)
Yongchang Zhang, et al.
Request article

Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single Center Study (Original Report)
Jatinder Kaur Lamba, et al.
Request article

Publishing March 22, 2023, 4:00 PM ET:

The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer (Editorial)
Andrew Armstrong, et al.
Request article

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase 1b, Open-label Study (Original Report)
Adil Daud, et al.
Request article

Cascade Analysis for Women Presenting With Breast Concerns to a Zonal Hospital in Mwanza, Tanzania (Original Report)
Anne Rositch, et al.
Request article

Analysis of the Mortality Trends of 23 Major Cancers in the Indian Population Between 2000 and 2019: A Joinpoint Regression Analysis (Original Report)
Ajil Shaji, et al.
Request article

Publishing March 21, 2023, 4:00 PM ET:

Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer (Original Report)
Jennifer Kay Plichta, et al.
Request article

Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting (Original Report)
Melissa P. Beauchemin, et al.
Request article

Published March 20, 2023, 4:00 PM ET:

Isolated Hepatic Perfusion with Melphalan for Patients with Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM trial) (Original Report)
Roger Olofsson Bagge, et al.
Request article

Published March 17, 2023, 4:00 PM ET:

Definition and clinical significance of the MGUS-like phenotype: a study in 5,117 patients with monoclonal gammopathies (Original Report)
Bruno Paiva, et al.
Request article

Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes (Original Report)
Matteo Giovanni Della Porta, et al.
Request article

Causal Inference in Oncology Comparative Effectiveness Research using Observational Data: Are Instrumental Variables Underutilized? (Editorial)
Ya-Chen Tina Shih, et al.
Request article

Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer (Original Report)
Mikael Eriksson, et al.
Request article

Published March 16, 2023, 4:00 PM ET:

Implementing Evidence-Based Tobacco Treatment Interventions in Oncology to Achieve Optimal Outcomes (Editorial)
Jamie L. Studts, et al.
Request article

Novel Genetic Subtypes of Urothelial Carcinoma with Differential Outcomes on Immune Checkpoint Blockade (Original Report)
Michal Sarfaty, et al.
Request article

Real-World Experience with NTRK Fusion-Positive Tumors and TRK Inhibitors in Veterans (Original Report)
Katherine I. Zhou, et al.
Request article

Pathway Alterations in Stage II/III Primary Melanoma (Original Report)
Ronglai Shen, et al.
Request article

Using Recurrent Neural Networks to Extract High-Quality Information From Lung Cancer Screening Computerized Tomography Reports for Inter-Radiologist Audit and Feedback Quality Improvement (Original Report)
Yucheng Zhang, et al.
Request article

Published March 15, 2023, 4:00 PM ET:

Efficacy of a Smoking Cessation Intervention for Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer: A Randomized Controlled Trial (Original Report)
Jennifer Irvine Vidrine, et al.
Request article

Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country (Original Report)
Bryan Valcarcel, et al.
Request article

Examining Cancer Patients’ Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics (Original Report)
Adedayo A. Onitilo, et al.
Request article

The US President’s Cancer Panel: A Model For Gathering Country-Level Input to Inform Cancer Control Policy and Program Initiatives (Original Report)
Rachel Hanisch, et al.
Request article

Published March 13, 2023, 4:00 PM ET:

Surgery in Early Metastatic Seminoma (SEMS): A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy (Original Report)
Siamak Daneshmand, et al.
Request article 

Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma (Original Report)
Matthew Firpo, et al.
Request article 

Published March 10, 2023, 4:00 PM ET:

A Phase 2 Clinical Trial of Axitinib and Avelumab in Patients with Recurrent/Metastatic Adenoid Cystic Carcinoma (Original Report)
Renata Ferrarotto, et al.
Request article 

Recently published Journal articles are featured on the homepage of each ASCO Journal website. Credentialed media can directly access these articles using their Media HQ login information on the Journal website. You will only need to log in once to access content for all ASCO Journals:

To apply for ASCO media credentials or renew your credentials, visit ASCO’s Media Headquarters and click “Create Account” or log in with your existing account information. To request your username or reset your password, click “Need Help. After submitting the required documentation, you will receive an email notification once your media credentials are approved. Your access to Journal articles will be activated within one week of approval. As you await access, once you have received notification of approved media credentials, submit your requested articles to Journal Request to receive them by email. 

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.